Clinical Center; Notice of Closed Meeting, 95153 [2016-31171]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Notices
would constitute a clearly unwarranted
invasion of personal privacy.
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Peer Review Meeting.
Date: January 17, 2017.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Audrey O. Lau, Ph.D.,
Scientific Review Officer, Scientific Review
Program, DEA/NIAID/NIH/DHHS, 5601
Fishers Lane, MSC–9823, Rockville, MD
20852, 240–669–2081, audrey.lau@
niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Peer Review Meeting.
Date: January 18, 2017.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: B. Duane Price, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
RM 3G50, National Institutes of Health,
NIAID, 5601 Fishers Lane, MSC 9823,
Bethesda, MD 20892–9823, 240–669–5074,
pricebd@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01).
Date: January 18, 2017.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Annie Walker-Abbey,
Scientific Review Officer, Scientific Review
Program, NIAID/NIH/DHHS, 5601 Fishers
Lane, Room 3E70A, Rockville, MD 20852,
240–627–3390, aabbey@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: December 20, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; TRND3.
Date: January 18, 2017.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Democracy One, Room 987, 6701 Democracy
Blvd., Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Victor Henriquez, Ph.D.,
Scientific Review Officer, Office of Scientific
Director, National Center for Advancing
Translational Sciences (NCATS), National
Institutes of Health, 6701 Democracy Blvd.,
Democracy 1, Room 1080, Bethesda, MD
20892–4878, 301–451–2405, henriquv@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: December 20, 2016.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–31173 Filed 12–23–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
[FR Doc. 2016–31175 Filed 12–23–16; 8:45 am]
Clinical Center; Notice of Closed
Meeting
BILLING CODE 4140–01–P
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Board
VerDate Sep<11>2014
20:45 Dec 23, 2016
Jkt 241001
PO 00000
Frm 00056
Fmt 4703
Sfmt 9990
95153
of Scientific Counselors of the NIH
Clinical Center.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
CLINICAL CENTER, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors of the NIH Clinical Center.
Date: January 23–24, 2017.
Time: January 23, 2017, 8:00 a.m. to 12:15
p.m.
Agenda: To review and evaluate the
Department of Transfusion Medicine.
Place: National Institutes of Health,
Building 10, Rm: 10–42551, 10 Center Drive,
Bethesda, MD 20892.
Time: January 23, 2017, 1:00 p.m. to 4:45
p.m.
Agenda: To review and evaluate the
Department of Transfusion Medicine.
Place: National Institutes of Health,
Building 10, Rm: 10–42551, 10 Center Drive,
Bethesda, MD 20892.
Time: January 24, 2017, 8:00 a.m. to 12:00
p.m.
Agenda: To review and evaluate the
Department of Transfusion Medicine.
Place: National Institutes of Health,
Building 10, Rm: 10–42551, 10 Center Drive,
Bethesda, MD 20892.
Contact Person: David K. Henderson, MD,
Deputy Director for Clinical Care, Office of
the Director, Clinical Center, National
Institutes of Health, Building 10, Room 6–
1480, Bethesda, MD 20892, (301) 496–3515.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Dated: December 20, 2016.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–31171 Filed 12–23–16; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\27DEN1.SGM
27DEN1
]]>Agencies
[Federal Register Volume 81, Number 248 (Tuesday, December 27, 2016)]
[Notices]
[Page 95153]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-31171]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Clinical Center; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Board of Scientific Counselors of the NIH Clinical Center.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), Title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the CLINICAL
CENTER, including consideration of personnel qualifications and
performance, and the competence of individual investigators, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Board of Scientific Counselors of the NIH
Clinical Center.
Date: January 23-24, 2017.
Time: January 23, 2017, 8:00 a.m. to 12:15 p.m.
Agenda: To review and evaluate the Department of Transfusion
Medicine.
Place: National Institutes of Health, Building 10, Rm: 10-42551,
10 Center Drive, Bethesda, MD 20892.
Time: January 23, 2017, 1:00 p.m. to 4:45 p.m.
Agenda: To review and evaluate the Department of Transfusion
Medicine.
Place: National Institutes of Health, Building 10, Rm: 10-42551,
10 Center Drive, Bethesda, MD 20892.
Time: January 24, 2017, 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate the Department of Transfusion
Medicine.
Place: National Institutes of Health, Building 10, Rm: 10-42551,
10 Center Drive, Bethesda, MD 20892.
Contact Person: David K. Henderson, MD, Deputy Director for
Clinical Care, Office of the Director, Clinical Center, National
Institutes of Health, Building 10, Room 6-1480, Bethesda, MD 20892,
(301) 496-3515.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Dated: December 20, 2016.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-31171 Filed 12-23-16; 8:45 am]
BILLING CODE 4140-01-P
